Automated Induced Pluripotent Stem Cell (iPSC) Allogeneic Therapy Foundry Cap Rate 2026

Underwrite GMP Class A/B automated robotic iPSC differentiation and cryogenic banking foundry cleanroom suites for off-the-shelf allogeneic cell therapies, $480/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

GMP iPSC Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP iPSC Facility Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation